Cargando…

High fluorodeoxyglucose ((18)F)PET-uptake lymph nodes in a patient with chordoma: Tumor metastasis or sarcoidosis?

Patient: Male, 48 Final Diagnosis: Chordoma Symptoms: — Medication: — Clinical Procedure: — Specialty: Neurology OBJECTIVE: Challenging differential diagnosis BACKGROUND: Fluorodeoxyglucose positron emission tomography (FDG-PET) has been used in imaging and staging of malignancies including sacral c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharavi, Mohamad Hossain, Wu, Hope Hueizhi, Toms, Steven A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783480/
https://www.ncbi.nlm.nih.gov/pubmed/24086794
http://dx.doi.org/10.12659/AJCR.889329
Descripción
Sumario:Patient: Male, 48 Final Diagnosis: Chordoma Symptoms: — Medication: — Clinical Procedure: — Specialty: Neurology OBJECTIVE: Challenging differential diagnosis BACKGROUND: Fluorodeoxyglucose positron emission tomography (FDG-PET) has been used in imaging and staging of malignancies including sacral chordomas. CASE REPORT: The author’s report describes the coincident pathological diagnosis of sarcoidosis in a 48-year-old male patient with a recurrent sacral chordoma. Chordoma is a low grade malignancy with frequent systemic metastases in advanced disease. Both metastases and sarcoidosis may be high FDG uptake. Unexpected PET findings need to be biopsied in order to make appropriate clinical decision in the management of chordoma. CONCLUSIONS: Lymph nodes involvement in sarcoidosis and neoplastic disease can have similar FDG-PET manifestations.